Tozaro

Synthetic Smart Polymer affinity ligands for purifying viral vectors and biologics, for cell and gene therapy manufacturers

Sharnbrook, United KingdomFounded 2015tozaro.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-30

About Tozaro

Tozaro develops Smart Polymer™ synthetic affinity ligands for downstream bioprocessing. Its platform combines computational modelling, machine learning and chemical synthesis to design ligands tailored to a specific target and chromatography application.

The company's first products focus on viral vector purification, including lentivirus and AAV. It works with biotechs, CDMOs and academia on purification solutions for advanced therapies, and its stated mission is to commercialise Smart Polymer reagents.

Tozaro is registered in the United Kingdom, with its headquarters in Sharnbrook, and was founded in 2015. Its leadership team includes Chief Executive Officer Jason Slingsby and Chief Financial Officer Guy Leaver.

Product: Smart Polymer™ synthetic affinity ligands (bead, membrane and monolith formats) for viral vector and biologics purification.

Jobs at Tozaro

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Treos Bio

    Develops peptide-based cancer immunotherapies for patients and pharmaceutical development partners
    London, United KingdomBiotech & pharmaFounded 2016
    New on Evolc
  • Trimtech Therapeutics

    Develops small-molecule protein degraders for Alzheimer's, Parkinson's and other neurodegenerative and inflammatory diseases
    Cambridge, United KingdomBiotech & pharmaFounded 2023
    Young companyNew on Evolc
  • TTP

    Robotic manufacturing automation for cell therapy developers and manufacturers
    Melbourn, United KingdomBiotech & pharmaFounded 202245 open jobs
    Young company
  • Veramed

    Clinical trial biometrics services (data management, biostatistics, programming) for pharma and biotech sponsors
    Twickenham, United KingdomBiotech & pharmaFounded 201015 open jobs
    New on Evolc
  • Verdiva Bio

    Develops once-weekly peptide medicines for obesity and cardiometabolic disease, with a lead drug in Phase 2 trials
    London, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc
  • Waymade PLC

    Specialty pharmaceutical company developing, licensing and commercialising generic and niche medicines for patients worldwide
    Basildon, United KingdomBiotech & pharmaFounded 19843 open jobs
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Tailwind CSS
  • WordPress
  • jQuery
  • nginx